MSD DPP-4 inhibitor doesn’t increase CV risk in diabetes, heart patients


Sigma trials diabetes pilot; index finger with pinprick of blood as in diabetes testing
small drop of blood on the tip of a finger

A major study of 14,671 patients from 38 countries with type 2 diabetes and established cardiovascular disease has found that a DPP-4 inhibitor does not increase the risk for major adverse CV events, hospitalisation for heart failure or adverse events.



This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Register here

Forgot Password?

Previous Guild member fees slashed by 25% for a year
Next Colorectal cancer treatment shows benefit

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

1 Comment

  1. Tara Johns
    11/06/2015

    I feel sorry for the people with
    diabetes that haven’t yet figured out that the secret to curing it, without
    relying on bullcrap meds that just treat it, is in their diet and lifestyle.
    Luckily I was able to beat my own Type 2 Diabetes when I figured out that
    metformin was ineffective, my doctor wasn’t much help compared to natural cures
    available to me. Natural cures are effective, safe, and largely FREE or
    EXTREMELY cheap. Why are people NEGLECTING TO RESEARCH THEM?

    The way to beat diabetes naturally
    is covered extremely well in the Diabetes Destroyer book (It’s better explained
    here: TINYURL.COM/DIABETES-DESTROY ). Essentially, the book
    guided me towards improvements in my health that were so easy to understand
    that I read it from cover to cover in the same night I discovered it. Today, a
    few months later, I’ve dropped 30 pounds. My blood sugar is down from 140 to
    70-80 (fasted). I feel better than ever and I’m never going to have to deal
    with insulin injections. It did more for me than Metformin and the ADA diet
    ever could.

Leave a reply